ES2108680T3 - Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento. - Google Patents

Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.

Info

Publication number
ES2108680T3
ES2108680T3 ES88870191T ES88870191T ES2108680T3 ES 2108680 T3 ES2108680 T3 ES 2108680T3 ES 88870191 T ES88870191 T ES 88870191T ES 88870191 T ES88870191 T ES 88870191T ES 2108680 T3 ES2108680 T3 ES 2108680T3
Authority
ES
Spain
Prior art keywords
manufacture
desoxinojirimicina
medicinal product
butyl derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88870191T
Other languages
English (en)
Inventor
Raymond Allen Dwek
George William John Fleet
Thomas William Rademacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/248,461 external-priority patent/US4849430A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2108680T3 publication Critical patent/ES2108680T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL N - N - BUTIL DERIVADO DE DESOXINOJIRIMICINA O UNA SAL SUYA, FARMACEUTICAMENTE ACEPTABLE, ES UTIL PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL SIDA.
ES88870191T 1987-12-21 1988-12-20 Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento. Expired - Lifetime ES2108680T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13622487A 1987-12-21 1987-12-21
US16606588A 1988-03-09 1988-03-09
US07/248,461 US4849430A (en) 1988-03-09 1988-09-23 Method of inhibiting virus

Publications (1)

Publication Number Publication Date
ES2108680T3 true ES2108680T3 (es) 1998-01-01

Family

ID=27384837

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88870191T Expired - Lifetime ES2108680T3 (es) 1987-12-21 1988-12-20 Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.

Country Status (15)

Country Link
EP (1) EP0324328B1 (es)
JP (1) JPH01203326A (es)
KR (1) KR910010020B1 (es)
AT (1) ATE159427T1 (es)
AU (1) AU605661B2 (es)
CA (1) CA1316459C (es)
DE (1) DE3856052T2 (es)
DK (1) DK175094B1 (es)
ES (1) ES2108680T3 (es)
GR (1) GR3025518T3 (es)
IE (1) IE81173B1 (es)
IL (1) IL88740A (es)
NZ (1) NZ227411A (es)
OA (1) OA09027A (es)
PT (1) PT89266B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
AU753336B2 (en) * 1997-11-10 2002-10-17 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6809083B1 (en) 1998-02-12 2004-10-26 Richard A. Mueller Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
US6515028B1 (en) 1999-02-12 2003-02-04 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
EP1165080A2 (en) 1999-02-12 2002-01-02 G.D. SEARLE & CO. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US20080138351A1 (en) * 2006-08-02 2008-06-12 United Therapeutics Corporation Liposome treatment of viral infections
CN115806913B (zh) * 2022-10-21 2023-09-08 福建省农业科学院植物保护研究所 野尻链霉菌（Streptomyces nojiriensis）菌株9-13及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
JPS5311800A (en) * 1976-07-20 1978-02-02 Asahi Chemical Ind Method of well preserving and transporting live fish and apparatus therefor
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
IE883793L (en) 1989-06-21
DK707988D0 (da) 1988-12-20
CA1316459C (en) 1993-04-20
EP0324328A2 (en) 1989-07-19
IL88740A (en) 1993-01-31
KR910010020B1 (ko) 1991-12-10
JPH0521891B2 (es) 1993-03-25
PT89266B (pt) 1993-11-30
KR890009401A (ko) 1989-08-01
IL88740A0 (en) 1989-07-31
OA09027A (fr) 1991-03-31
PT89266A (pt) 1989-12-29
ATE159427T1 (de) 1997-11-15
DE3856052T2 (de) 1998-02-19
EP0324328A3 (en) 1990-06-20
AU605661B2 (en) 1991-01-17
IE81173B1 (en) 2000-05-31
DK175094B1 (da) 2004-06-01
JPH01203326A (ja) 1989-08-16
DK707988A (da) 1989-06-22
EP0324328B1 (en) 1997-10-22
GR3025518T3 (en) 1998-02-27
NZ227411A (en) 1997-03-24
DE3856052D1 (de) 1997-11-27
AU2706788A (en) 1989-06-22

Similar Documents

Publication Publication Date Title
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
FI862011A0 (fi) Terapeutiska nukleosider.
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DE3875769D1 (de) Therapeutische nukleoside.
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DE69023708D1 (de) Anti-hiv-heilmittel.
ES2094757T3 (es) Un factor megacariocitopoyetico.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
SE9000288D0 (sv) New use
IT1219938B (it) Impiego farmaceutico del dietila-minoetil-destrano

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 324328

Country of ref document: ES